REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Discover the only FDA-Approved treatment for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Otsuka and Lundbeck Announce U.S. Food and Drug Administration (FDA) Approval of Supplemental New Drug Application (sNDA) for REXULTI® ( brexpiprazole) for the Treatment of Agitation Associated with Dementia Due to Alzheimer's Disease

Otsuka and Lundbeck Announce REXULTI for Alzheimer's Agitation

Otsuka, Lundbeck get Adcom for Rexulti in Alzheimer agitation

REXULTI® (brexpiprazole), Agitation associated with dementia due to Alzheimer's disease

Lundbeck, Otsuka's Rexulti wins FDA nod for Alzheimer's agitation

Otsuka, Lundbeck's sNDA for Rexulti received US FDA approval

FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer's Disease - US FDA

Rexulti: Side effects, dosage, alternatives, and more

agitation that may happen with dementia due to Alzheimer's disease Questionnaire

Rexulti Commercial #2 (2023)

Medicare coverage debates amplify as FDA approves Rexulti for Alzheimer's agitation

JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer's Disease

FDA Approves Rexulti for Treating Agitation Due to Alzheimer's - MyChesCo

Jeff Leininger on LinkedIn: Otsuka Announces New FDA Approval